Search

Dennis H. Pedder

Examiner (ID: 14040, Phone: (571)272-6667 , Office: P/3612 )

Most Active Art Unit
3612
Art Unit(s)
2899, 3102, 3106, 3612, 3642
Total Applications
5987
Issued Applications
4919
Pending Applications
211
Abandoned Applications
929

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12912691 [patent_doc_number] => 20180196073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => Methods of Assessing Future Memory Loss by Measuring Polyunsaturated Fatty Acids [patent_app_type] => utility [patent_app_number] => 15/580984 [patent_app_country] => US [patent_app_date] => 2016-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11784 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580984 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/580984
Methods of assessing future memory loss by measuring polyunsaturated fatty acids Jun 7, 2016 Issued
Array ( [id] => 12794971 [patent_doc_number] => 20180156826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM SPECTRUM DISORDER [patent_app_type] => utility [patent_app_number] => 15/580576 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15701 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580576 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/580576
COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM SPECTRUM DISORDER Jun 2, 2016 Abandoned
Array ( [id] => 17221826 [patent_doc_number] => 11174317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-16 [patent_title] => Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient [patent_app_type] => utility [patent_app_number] => 15/579309 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 13235 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579309 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/579309
Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient Jun 2, 2016 Issued
Array ( [id] => 15247055 [patent_doc_number] => 10509045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-17 [patent_title] => Methods for diagnosing Huntington's disease [patent_app_type] => utility [patent_app_number] => 15/577995 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 162 [patent_no_of_words] => 11377 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577995 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/577995
Methods for diagnosing Huntington's disease May 26, 2016 Issued
Array ( [id] => 12746254 [patent_doc_number] => 20180140585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => BIOMOLECULES INVOLVED IN ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 15/577522 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577522 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/577522
Biomolecules involved in Alzheimer's disease May 26, 2016 Issued
Array ( [id] => 11060995 [patent_doc_number] => 20160257957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/158995 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 42461 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158995 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/158995
METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS May 18, 2016 Abandoned
Array ( [id] => 12773491 [patent_doc_number] => 20180149665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => Metabolic Biomarkers for Memory Loss [patent_app_type] => utility [patent_app_number] => 15/575115 [patent_app_country] => US [patent_app_date] => 2016-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11973 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575115 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/575115
Metabolic biomarkers for memory loss May 17, 2016 Issued
Array ( [id] => 12261749 [patent_doc_number] => 20180080946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'METHOD FOR DIAGNOSING DISEASES THROUGH OLIGOMER ANALYSIS OF ABNORMALLY AGGREGATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/565503 [patent_app_country] => US [patent_app_date] => 2016-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3729 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565503 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/565503
Method for diagnosing diseases through oligomer analysis of abnormally aggregated proteins May 17, 2016 Issued
Array ( [id] => 11130598 [patent_doc_number] => 20160327573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Methods for Diagnosing Onset and Monitoring Progression of Huntington\'s Disease' [patent_app_type] => utility [patent_app_number] => 15/148498 [patent_app_country] => US [patent_app_date] => 2016-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11285 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148498 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/148498
Methods for Diagnosing Onset and Monitoring Progression of Huntington's Disease May 5, 2016 Abandoned
Array ( [id] => 13625415 [patent_doc_number] => 20180364259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => ASTROCYTE TRAUMATOME AND NEUROTRAUMA BIOMARKERS [patent_app_type] => utility [patent_app_number] => 15/570982 [patent_app_country] => US [patent_app_date] => 2016-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570982 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/570982
Astrocyte traumatome and neurotrauma biomarkers May 4, 2016 Issued
Array ( [id] => 12212384 [patent_doc_number] => 09909182 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-03-06 [patent_title] => 'Methods for identifying subjects susceptible to charcot-marie-tooth neuropathy type 1C' [patent_app_type] => utility [patent_app_number] => 15/145652 [patent_app_country] => US [patent_app_date] => 2016-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11582 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15145652 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/145652
Methods for identifying subjects susceptible to charcot-marie-tooth neuropathy type 1C May 2, 2016 Issued
Array ( [id] => 11123443 [patent_doc_number] => 20160320417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHODS AND KITS FOR DETERMINING RISK FOR DEVELOPING ALZHEIMER\'S DISEASE AND PREVENTION OR TREATMENT THEREOF' [patent_app_type] => utility [patent_app_number] => 15/143234 [patent_app_country] => US [patent_app_date] => 2016-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12293 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15143234 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/143234
METHODS AND KITS FOR DETERMINING RISK FOR DEVELOPING ALZHEIMER'S DISEASE AND PREVENTION OR TREATMENT THEREOF Apr 28, 2016 Abandoned
Array ( [id] => 13481695 [patent_doc_number] => 20180292390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => NOVEL SLICE CULTURES AND METHODS FOR DIAGNOSING NEURONAL DEGENERATION DISEASES [patent_app_type] => utility [patent_app_number] => 15/567897 [patent_app_country] => US [patent_app_date] => 2016-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11353 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567897 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/567897
NOVEL SLICE CULTURES AND METHODS FOR DIAGNOSING NEURONAL DEGENERATION DISEASES Apr 24, 2016 Abandoned
Array ( [id] => 11271866 [patent_doc_number] => 20160334413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC METHODS FOR AUTISM SPECTRUM DISORDERS AND OTHER CONDITIONS' [patent_app_type] => utility [patent_app_number] => 15/136021 [patent_app_country] => US [patent_app_date] => 2016-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22098 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136021 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/136021
Therapeutic and diagnostic methods for autism spectrum disorders and other conditions Apr 21, 2016 Issued
Array ( [id] => 12685417 [patent_doc_number] => 20180120305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage [patent_app_type] => utility [patent_app_number] => 15/565753 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7068 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565753 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/565753
Prognostic and diagnostic glycan-based biomarkers of brain damage Apr 13, 2016 Issued
Array ( [id] => 12702265 [patent_doc_number] => 20180125921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION [patent_app_type] => utility [patent_app_number] => 15/565409 [patent_app_country] => US [patent_app_date] => 2016-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565409 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/565409
USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION Apr 7, 2016 Abandoned
Array ( [id] => 16925544 [patent_doc_number] => 11047009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Blood biomarkers for suicidality [patent_app_type] => utility [patent_app_number] => 15/091706 [patent_app_country] => US [patent_app_date] => 2016-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 37 [patent_no_of_words] => 17707 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15091706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/091706
Blood biomarkers for suicidality Apr 5, 2016 Issued
Array ( [id] => 16384443 [patent_doc_number] => 10809271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-20 [patent_title] => Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries [patent_app_type] => utility [patent_app_number] => 15/559001 [patent_app_country] => US [patent_app_date] => 2016-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50625 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559001 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/559001
Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries Mar 27, 2016 Issued
Array ( [id] => 11270541 [patent_doc_number] => 20160333088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'METHODS' [patent_app_type] => utility [patent_app_number] => 15/063775 [patent_app_country] => US [patent_app_date] => 2016-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24205 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063775 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/063775
METHODS Mar 7, 2016 Abandoned
Array ( [id] => 12185449 [patent_doc_number] => 20180044386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'PEPTIDE' [patent_app_type] => utility [patent_app_number] => 15/554890 [patent_app_country] => US [patent_app_date] => 2016-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554890 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/554890
Peptide Mar 1, 2016 Issued
Menu